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Dear Editor,
We describe two cases of Hantavirus infection 
in the town of Santa Cruz do Sul, state of Rio 
Grande do Sul, Brazil, that mimicked primarily 
community-acquired pneumonia. 
Case 1 was a 28-year-old married male in-
dividual, who worked as a farmer. On 11/11/09, 
he came to the Emergency Ward, with a his-
tory of fever, dyspnea, general myalgia (pre-
dominantly in the calves), nausea, tachycardia, 
periods of hypotension, weight loss and night 
sweats in the past three days. A chest x-ray 
showed nonspecific interstitial infiltrate. The 
patient was admitted to the Intensive Care Unit 
(ICU) due to hemodynamic and respiratory 
instability for noninvasive ventilatory support, 
without vasoactive drugs. Empiric antimicro-
bial therapy was started with levofloxacin and 
sulfamethoxazole/trimethoprim, due to the di-
agnostic hypotheses of severe community-ac-
quired pneumonia and pneumocystosis related 
to possible acquired immunodeficiency, which 
was later ruled out (nonreactive anti-HIV test); 
treatment was withdrawn and the patient was 
maintained on quinolone therapy, being dis-
charged from the ICU on 11/12/09 and from 
the hospital on 11/17/09. 
Case 2 was a 15-year-old high-school fe-
male student. On 11/30/09, she started to 
have fever, disseminated macular exanthema 
that progressed into petechiae, mainly in the 
lower limbs, and periods of hypotension. On 
12/01/09, a chest x-ray disclosed diffuse bilater-
al infiltrate and a chest tomography confirmed 
the findings, showing ground-glass opacities 
in the central pulmonary areas with lymphatic 
thickening and moderate bilateral pleural effu-
sion. After two days, the patient’s clinical con-
dition worsened (with somnolence, confusion, 
hemoptoic vomiting, tachypnea and dyspnea) 
and she was admitted to the ICU for respira-
tory monitoring and noninvasive mechanical 
ventilation, with vasoactive drugs. 
Treatment was started with ceftriaxone 
and azithromycin due to the hypothesis of 
severe community-acquired pneumonia and 
meningococcemia (emergency diagnosis). On 
12/08/2009 the patient was discharged from 
the ICU, in spite of alterations in liver injury 
tests and was finally discharged from the hos-
pital on 12/09/2009.
The Santa Cruz do Sul region is endemic 
for Leptospirosis and Hantaviruses in RS. Since 
2006, the protocols of severe pneumonia cases 
include serology for these two types of hemor-
rhagic fevers, when relevant (in Case 1, throm-
bocytopenia and respiratory failure; in Case 2, 
increase in aminotransferase levels and respira-
tory failure) and in time according to the labo-
ratory routine. The laboratory assessment flow 
chart is shown in Table 1.
Hantavirus infection is a worldwide dis-
ease that is often underdiagnosed due to its 
rapid progression and unfavorable evolution. 
It is caused by an arbovirus of the Bunyaviri-
dae family, genus Hantavirus. The disease has 
two clinical presentations: hemorrhagic fever 
with renal syndrome (HFRS) and Hantavirus 
cardiopulmonary syndrome (HCPS).1 The 
HFRS is characterized by fever, chills, retro-
orbital headache, photophobia, myalgia, ab-
dominal pain, nausea and vomiting, cranial 
exanthema, as well as petechiae in the soft 
palate and axillary region, which develop into 
hypotension and kidney failure.2 The HCPS 
presents as fever, diarrhea, headache, myalgia, 
nausea, vomiting, sudoresis and vertigo, with 
cardiovascular and respiratory involvement, 
similar to the adult respiratory distress syn-
drome.3 The differential diagnosis with other 
hemorrhagic fevers is mandatory for adequate 
clinical conduct, as well as environmen-
tal control.4 The differential diagnosis with 
severe community-acquired pneumonias is 
clinically and epidemiologically relevant. The 
anamnesis, which includes environmental 
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Table 1. Laboratory assessment of Hantavirus infection cases 
Laboratory tests Case 1 Case 2
 Admission ICU discharge Admission ICU discharge
Creatinine (mg/dL) 1.0 0.7 0.8 0.9
Urea (mg/dL) 39.0 - 18.0 24.0
Hematocrit (%) 45.4 42.8 32.6 32.7
Hemoglobin (mg/dL) 15.0 14.2 10.6 10.5
Leukocytes (mm3) 6,320 4,700 2,600 6,920
Platelets (mm3) 43,000 45,000 131,000 303,000
pH 7.4 7.5 7.5 7.4
PaO2 (mmHg) 67.1 81.0 64.6 104.9
HCO3 (mmol/L) 15.7 23.6 22.6 18.6
Base excess (mEq/L) -5.9 +2.1 +1.3 -3.5
Oxygen arterial saturation (%) 94.2 96.8 94.3 98.0
Aspartate aminotransferase (UI/L) 28.0 40.0 27.0 173.0
Alanine aminotransferase (UI/L) 23.0 28.0 8.0 129.0
Lactate dehydrogenase (mg/dL) 592.0 - 209.0 414.0
Serology for HIV* - Non-reactive Non-reactive -
Serology for Leptospirosis** - Non-reactive - Non-reactive
Serology for Hantavirus*** - IgM Positive - IgM Positive
* ELISA, enzyme linked immunosorbent assay
** MAT, microscopic agglutination test - Laboratório Central do Estado, RS, Brazil
*** IgM antibody capture - Instituto Adolf Lutz, SP, Brazil
assessment, is crucial, especially in severe cases. How-
ever, the empiric and intensive support therapies are 
mandatory to decrease the morbidity and mortality. The 
confirmation of suspected diagnoses will be adequate 
only when the collection follows the incubation period 
of each infectious disease, taking into account the most 
prevalent ones in the community. A proactive attitude 
by the epidemiologic surveillance system regarding sus-
pected cases of HCPS and its clinical investigation are 
crucial to consolidate the knowledge of the natural his-
tory of the disease. 
[Braz J Infect Dis 2011;15(3):298-299]©Elsevier Editora Ltda.
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